METHOD FOR MANUFACTURING A MEDICATED DISPOSABLE PESSARY AND MEDICATED DISPOSABLE PESSARY

Abstract: The present invention relates to a method for manufacturing a medicated disposable pessary, consisting of a porous spongy synthetic material. According to the present method a pessary comprising a resilient synthetic ring is manufactured by compressing a porous spongy synthetic material with a relatively large thickness into the desired shape, the thickness of the porous spongy synthetic material being remarkably reduced with respect to its original thick­ ness, followed by curing the resilient synthetic ring and the compressed shaped material together to form the desired pessary, and impregnating the pessary obtained with a solu­ tion of at least one medication. Furthermore the present invention comprises a medi­ cated pessary consisting of a resilient synthetic ring with a suitable diameter and a porous spongy synthetic material secured thereto by curing, which is impregnated with a solu­ tion of at least one medication.

Description: The present invention relates to a method for manu­ facturing a medicated disposable pessary, consisting of a porous spongy synthetic material, and to a medicated dis­ posable pessary. Such a method for manufacturing a medicated disposable pessary is disclosed in U.S. patent specification no. 4.393.871. According to this known method, at first the porous spongy material is prepared by mixing a polyurethane prepolymer with an aqueous solution of for instance a spermicide/surfactant. After mixing, the blend is poured into a polymeric cavity mould, where it begins to foam as the hydroxyl groups from the water react with the isocyanate groups to form polyurethane. The special feature of this known method is the obtaining of a synergistic combination of a spermicide serving as surfactant and a polyurethane prepolymer. The pessary is provided with a removal means, which is secured to the polyurethane during foaming. The known pessary thus obtained has the important disadvantage of not being anchorable in the vagina, thus being subject to displacement, which involves the risc for the woman of getting pregnant. A further disadvantage is that the pessary produced by the prior art method is voluminous. Finally said pessary should be wetted prior to insertion into the vagina. The present invention is directed to a method, in which the above mentioned disadvantages are efficiently removed. To this end the present invention provides a method for manufacturing a medicated disposable pessary consisting of a porous spongy synthetic material, characterized in that a pessary comprising a resilient synthetic ring is manufactured by compressing a porous spongy synthetic material having a relatively large thickness into the desired shape, the thickness of the porous spongy synthetic material being remarkably reduced with respect to its original thickness, followed by curing the resilient synthetic ring and the compressed shaped material to­ gether to form the desired pessary, and impregnating the pessary obtained with a solution of at least one medication. Normally the thickness of the porous spongy synthetic material prior to compressing is 0,5-1,0 cm, said thickness being reduced after compression to 10-20% of its original thickness. It will be appreciated, that by this remarkable reduction of thickness of the porous spongy synthetic material an important decrease in volume of the pessary is obtained, having as favourable effect that the desired properties of foam, such as softness and the desired absorption respectively release of the medications, are retained. The resilient synthetic ring has such a diameter as to fix the pessary in the vagina, with the pessary blocking the cervix suitably and permanently, so that the chance of spermatozoa reaching the uterus is reduced to a minimum. The diameter of the resilient synthetic ring may vary in dependence of the size of the cervix and may amount to 5-10 cm. Usually, the compression of the porous spongy synthetic material is carried out at a temperature of 180-220°C and at a small pressure of less than 10 kg/cm². The curing, which secures the synthetic ring to the material compressed into shape, is conducted at 180-220°C and at a pressure of 70-115 kg/cm². According to the invention it has been found, that the curing of the invention provides a good adherence be­ tween the resilient synthetic ring and the porous material, so that even after a prolonged stay of the pessary in the vagina a release of the ring does not occur. According to the present invention, it is preferred to use as porous spongy synthetic material with a relatively great thickness a thermically cross-linked polyester poly­ urethane foam having a controlled pore size. The number of pores per linear centimeter amounts to 30-50. However, also other appropriate porous synthetic spongy materials may be used. According to the present invention good results are obtained when the resilient synthetic ring consists of a material having a melting point lower than the porous spongy synthetic material. A preferred pessary is obtained, according to the invention, by using as resilient synthetic ring an ethylene vinyl acetate ring and as porous spongy synthetic material thermically cross-linked polyester polyurethane foam. Finally, the obtained pessary is impregnated with a medication, preferably spermicides and/or other substances, after which the pessary thus impregnated is packed in an air/liquid tight unitary packing, in which packing it is traded. In addition to spermicides, such as nonoxynol-9, p-methanyl phenyl polyoxyethylene ether, polyoxyethylene oxypropylene stearate etc., other substances may be used, for instance fungicides, bactericides, virucides etc. A specially suitable spermicide is a mixture of non­ oxynol-9 and chlorhexidine gluconate. Further the present invention provides a medicated pessary, consisting of a resilient synthetic ring with a suitable diameter and a porous spongy synthetic material secured thereto by curing, which is impregnated with a solution of at least one medication. Preferably the resilient synthetic ring consists of ethylene vinyl acetate and the porous spongy synthetic material consists of compressed thermically cross-linked polyester polyurethane foam. The invention will be described in more detail by the following non-restrictive example. EXAMPLE A suitable disposable pessary according to the in­ vention is manufactured by compressing a thermically cross-­ linked polyester polyurethane foam with a thickness of approximately 0,75 cm into the desired shape at 200°C and at a pressure of 5 kg/cm², producing a 0,075 cm thick foam material. Then a resilient ethylene vinyl acetate ring of proper diameter, for example 6 cm, is secured to the com­ pressed spongy synthetic material by curing at 200°C and at a pressure of 100 kg/cm². Next the pessary thus obtained is impregnated with a solution of nonoxynol-9 and chlorhexidine gluconate as spermicide. Such a solution contains 3,3 ml of sterile water, 0,48 ml of nonoxynol-9 and 0,2 ml of 20% chlorhexidine gluconate. Finally, the pessary thus impregnated is packed in an air/liquid tight unitary packing. This packed pessary of the present invention is ready for distribution in a pharmacy, druggist's shop, etc.

Claims: 1. A method for manufacturing a medicated disposable pessary, consisting of a porous spongy synthetic material, characterized in that a pessary comprising a resilient synthetic ring is manufactured by compressing a porous spongy synthetic material with a relatively large thickness into the desired shape, the thickness of the porous spongy synthetic material being remarkably reduced with respect to its original thickness, followed by curing the resilient synthetic ring and the compressed shaped material together to form the desired pessary, and impregnating the pessary obtained with a solution of at least one medication. 2. The method of claim 1, characterized in that the thickness of the porous spongy synthetic material is prior to compression 0,5-1,0 cm and after compression 10-20% of its original thickness. 3. The method of claim 1 or 2, characterized in that the compression of the porous spongy synthetic material is carried out at a temperature of 180-220°C and at a small pressure of less than 10 kg/cm². 4. The method of claims 1 - 3, characterized in that the curing is carried out at a temperature of 180-220°C and at a pressure of 70-115 kg/cm². 5. The method of claims 1 - 4, characterized in that the porous spongy synthetic material with relatively large thickness is a thermically cross-linked polyester polyurethane foam having a controlled pore size. 6. The method of claims 1 - 4, characterized in that the resilient synthetic ring consists of a material having a melting point lower than the porous spongy synthetic material. 7. The method of claim 6, characterized in that the resilient synthetic ring consists of ethylene vinyl acetate, with the porous spongy synthetic material being thermically cross-linked polyester polyurethane foam. 8. The method of claims 1 - 7, characterized in that the pessary obtained is impregnated with spermicidal and/or other substances, after which it is packed in air/liquid tight unitary packings. 9. A medicated pessary consisting of a resilient synthetic ring with a suitable diameter and a porous spongy synthetic material secured thereto by curing, which is impregnated with a solution of at least one medication. 10. The pessary of claim 9, characterized in that the resilient synthetic ring consists of ethylene vinyl acetate and the porous spongy synthetic material consists of compressed thermically cross-linked polyester poly­ urethane foam.

Inventors: SPITS, MARC
Applicants: FUNDATECH S.A.
Application year: 1987
Main classification: A61F6
IPC codes: A61F6